Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by musingon Aug 22, 2004 8:28pm
402 Views
Post# 7838937

Jim Dinning neither gets nor doesn't get my vote

Jim Dinning neither gets nor doesn't get my voteWith respect to Alberta's debt free status and Dinning getting credit therefore, I would suggest its more realistic to think that OPEC, China (and Asia more generally), mother nature, the Russian government and legal system and the law of supply and demand who deserve the credit. As to Dinning stature, yes he is a good old boy in Alberta but I doubt whether this will be of much help on ONC's board. The Alberta government has a deplorable record in its support of venture enterprises, totally deplorable. Incidentally, and off topic, Alberta and Albertans would be much better off if their monies had been managed under either Alaska's and Norway's policies for oil monies -- much, much better off!!!!!!!
Bullboard Posts